Prosecution Insights
Last updated: April 19, 2026
Application No. 17/548,487

ANALYTE SENSORS FOR SENSING KETONES AND METHODS OF USING THE SAME

Non-Final OA §103
Filed
Dec 10, 2021
Examiner
CATINA, MICHAEL ANTHONY
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Abbott Laboratories
OA Round
3 (Non-Final)
31%
Grant Probability
At Risk
3-4
OA Rounds
5y 6m
To Grant
61%
With Interview

Examiner Intelligence

Grants only 31% of cases
31%
Career Allow Rate
167 granted / 535 resolved
-38.8% vs TC avg
Strong +30% interview lift
Without
With
+29.7%
Interview Lift
resolved cases with interview
Typical timeline
5y 6m
Avg Prosecution
54 currently pending
Career history
589
Total Applications
across all art units

Statute-Specific Performance

§101
20.6%
-19.4% vs TC avg
§103
36.8%
-3.2% vs TC avg
§102
11.9%
-28.1% vs TC avg
§112
28.0%
-12.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 535 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 2/3/26 has been entered. Response to Amendment Receipt is acknowledged of applicant's amendment filed on 2/3/26. Claims 4, 8-9 and 19 are cancelled. Claims 24-26 are new. Claims 1-3, 5-7, 10-18 and 20-26 are currently pending and an action on the merits is as follows. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3, 5, 10-14, 16, 20, 21 and 23 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yodfat et al. US 2010/0268043 in view of Cocco et al. “NADH oxidase from the extreme thermophile Thermus aquaticus YT-1” and Zweig US 2003/0068666. Regarding claim 1, Yodfat discloses an analyte sensor for detecting ketones in vivo, the sensor comprising: (i) at least a first working electrode ([FIG4a][¶52,79] cannula 6 is the tail and electrodes 100 and 900 are the sensors) comprising a conductive material ([¶92-93] the sensor are amperometric so the electrodes are conductive); (ii) a ketones-responsive active area disposed upon a surface of the first working electrode, wherein the ketones-responsive active area comprises an enzyme system comprising a β-hydroxybutyrate dehydrogenase ([FIG4a][¶52,79] the enzymes used are β-hydroxybutyrate dehydrogenase and salicyclate hydroxylase which oxidizes NADH to NAD+). wherein the ketones-responsive active area is responsive to ketones at a potential ([¶19] the voltage differential is measured of the working electrode and the reference). wherein a distal portion of the sensor is configured to be inserted into a subject’s skin to detect ketones in vivo ([FIG3a,4a] [¶52,79]). Yodfat does not specifically disclose using NADH oxidase or the potential range. Cocco teaches a similar analyte sensor that uses NADH oxidase ([pg. 267] an amperometric biosensor that uses NADH oxidase to produce hydrogen peroxide). Yodfat in view of Cocco teaches the ketones-responsive active area is responsive to ketones at a potential from about +0.2 V to about +0.5 V relative to an Ag/AgCl reference ([¶19] the voltage differential is measured of the working electrode and the reference. Yodfat and Cocco teach the claimed enzymes so the voltage response would be the same for the same ketones/analytes). Therefore, it would have been obvious to one of ordinary skill in the art prior to the time of filing to combine the NADH oxidase of Cocco with the device of Yodfat as it is the mere replacement of salicyclate hydroxylase with NADH oxidase to convert NADH to NAD+ while providing peroxide which is useful in biosensing assays ([pg. 267]). Yodfat does not specifically disclose a mass transport limiting membrane permeable to ketones that overcoats at least a portion of the ketones-responsive active area or that the working electrode comprises a conductive material that oxidizes hydrogen peroxide. Zweig teaches a similar glucose and ketone sensor that has a limiting membrane ([¶79-81] filtering layers block large components that are not the analytes being sensed) and an electrodes that oxidizes hydrogen peroxide ([¶58] silver chloride). Therefore, it would have been obvious to one of ordinary skill in the art prior to the time of filing to combine the limiting layer of Zweig with the sensor of Yodfat in order to block interferents ([¶79]). Regarding claim 2, Yodfat discloses the ketones-responsive active area does not include a redox mediator comprising a transition metal complex ([FIG4a][¶23,52,79] only β-hydroxybutyrate dehydrogenase is used). Regarding claims 3, 14 and 23, Yodfat discloses the ketones-responsive active area does not include a superoxide dismutase ([FIG4a][¶23,52,79] only β-hydroxybutyrate dehydrogenase is used). Regarding claims 5 and 16, Zweig teaches the ketones-responsive active area further comprises a stabilizer for stabilizing the enzyme system ([¶106] stabilizers are used). Regarding claims 10 and 20, Yodfat discloses the sensor further comprising: (iv) a second working electrode; and (v) a second active area disposed upon a surface of the second working electrode and responsive to a second analyte differing from ketones, wherein the second active area comprises at least one enzyme responsive to the second analyte ([¶24,52,79] glucose sensor electrode 900). Regarding claim 11, Zweig teaches further comprising a second mass transport limiting membrane overcoats the second active area ([¶79] the layer coats the electrodes). Regarding claim 12, Yodfat discloses the second analyte is glucose ([¶24,52,79] glucose sensor electrode 900). Regarding claim 13, Yodfat discloses a method for detecting ketones comprising: (i) exposing the analyte sensor of claim 1 to a fluid comprising ketones (ii) applying a potential to the first working electrode ([¶93] power is supplied for the reaction); (iii) obtaining a first signal at or above an oxidation-reduction potential of the ketones- responsive active area, the first signal being proportional to a concentration of ketones in a fluid contacting the ketones-responsive active area ([¶52] the electrical signal is proportional the ketone concentration); and (iv) correlating the first signal to the concentration of ketones in the fluid ([¶52]). Regarding claim 21, Zweig teaches the second membrane also overcoats the mass transport limiting membrane overcoating the ketones-responsive active area ([¶79]). Claim(s) 6, 7, 15, 17, 18 and 22 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yodfat et al. US 2010/0268043 in view of Cocco et al. and Zweig US 2003/0068666 further in view of Feldman et al. US 2010/0213082. Regarding claims 6 and 17, Yodfat as modified by Zweig does not disclose the mass transport limiting membrane comprises a polyvinylpyridine, a polyvinylimidazole, a polyvinylpyridine copolymer, a polyacrylate, a polyurethane, a polyether urethane or a combination thereof. Feldman teaches a similar glucose sensor that uses polyvinylpyridine ([¶85,86] PVP acts as a mass limiting layer). Therefore, it would have been obvious to one of ordinary skill in the art prior to the time of filing to combine the PVP of Feldman with the sensor of Yodfat in order to fine tune the layer/barrier for the analyte or species of interest reducing interferents and noise ([¶86]). Regarding claims 7 and 18, Feldman teaches the mass transport limiting membrane comprises a polyvinylpyridine ([¶85,86]). Regarding claim 15 and 22, Yodfat does not disclose the working electrode comprises platinum. Feldman teaches a similar glucose sensor that uses platinum electrodes ([¶34,64]). Therefore, it would have been obvious to one of ordinary skill in the art prior to the time of filing to combine the platinum electrode of Feldman with the sensor of Yodfat in order as it is now more than the substitution of one known element for another, platinum electrode replacing a carbon electrode, that would yield the predictable result of providing a conductive electrode ([¶64]). Claim(s) 24-26 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yodfat et al. in view of Cocco et al. and Zweig US further in view of Chen et al. US 2019/0320947. Regarding claims 24- 26, Yodfat does not specifically disclose the mass transport limiting membrane that overcoats the ketones-responsive active area is a bilayer membrane, wherein a lower layer of the bilayer membrane comprises a polyvinylpyridine polymer and wherein an upper layer of the bilayer membrane comprises a polyvinylpyridine-co-styrene copolymer. Chen teaches a similar analyte sensor that has a bilayer membrane composed of both polyvinylpyridine and polyvinylpyridine-co-styrene ([¶34]). Therefore, it would have been obvious to one of ordinary skill in the art prior to the time of filing to combine the device of Yodfat with teachings of Chen in order to have sufficient response stability of the sensor ([¶71]). Response to Arguments Applicant's arguments filed 2/3/26 have been fully considered but they are not persuasive. Regarding Applicant's arguments against the combination of Yodfat and Cocco, Examiner respectfully disagrees. Yodfat discloses a biosensor with an immobilized enzyme for sensing ketones. The signal is generated by the reaction of the enzyme coated electrode. The electrode is coated in HBDH which reacts to create NADH and acetoacetate and that is measured ([¶94]). Yodfat does not disclose the specific use of hydrogen peroxide in the reaction. Cocco teaches a biosensor applicable enzyme system that generates hydrogen peroxide for sensing. Yodfat already discloses the use of multiple enzymes bonded to the electrode sensing area and Cocco's use of NADH oxidase allows for the regeneration of the cofactor NAD+. The detection of hydrogen peroxide rather than just NADH allows the electrode to both sense the ketone and recycle the NADH into NAD+. Similarly the device could still function as Yodfat discloses as the oxidase is immobilized on the electrode just like the SHL. In regard to Cocco and Frew, they function the same as the electrode in the present device. Frew uses a different enzyme and Cocco specifically uses NADH oxidase to get the same reaction. The electrode produces the reaction through the bound enzyme. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL ANTHONY CATINA whose telephone number is (571)270-5951. The examiner can normally be reached 10-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Chen can be reached on 5712723672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL A CATINA/Examiner, Art Unit 3791 /TSE W CHEN/Supervisory Patent Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Dec 10, 2021
Application Filed
Jan 25, 2025
Non-Final Rejection — §103
May 16, 2025
Response Filed
Aug 07, 2025
Final Rejection — §103
Dec 11, 2025
Applicant Interview (Telephonic)
Dec 19, 2025
Response after Non-Final Action
Feb 03, 2026
Request for Continued Examination
Feb 22, 2026
Response after Non-Final Action
Mar 21, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599304
CONFIGURABLE HARDWARE PLATFORM FOR PHYSIOLOGICAL MONITORING OF A LIVING BODY
2y 5m to grant Granted Apr 14, 2026
Patent 12484853
SYSTEM AND METHOD FOR INTERACTING WITH AN IMPLANTABLE MEDICAL DEVICE
2y 5m to grant Granted Dec 02, 2025
Patent 12478282
METHODS AND SYSTEMS FOR COLLECTING SPIROMETRY DATA
2y 5m to grant Granted Nov 25, 2025
Patent 12471854
Systems and Methods For Monitoring a Patient
2y 5m to grant Granted Nov 18, 2025
Patent 12453483
SYSTEM AND METHOD FOR IDENTIFYING BLOOD PRESSURE ZONES DURING AUTOREGULATION MONITORING
2y 5m to grant Granted Oct 28, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
31%
Grant Probability
61%
With Interview (+29.7%)
5y 6m
Median Time to Grant
High
PTA Risk
Based on 535 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month